These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19126625)

  • 1. Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
    Binder G; Weber S; Ehrismann M; Zaiser N; Meisner C; Ranke MB; Maier L; Wudy SA; Hartmann MF; Heinrich U; Bettendorf M; Doerr HG; Pfaeffle RW; Keller E;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1182-90. PubMed ID: 19126625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G; Burman P; Wirén L; Engström BE; Nilsson AG; Ottosson M; Jonsson B; Bengtsson BA; Karlsson FA
    J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial.
    Rice SP; Agarwal N; Bolusani H; Newcombe R; Scanlon MF; Ludgate M; Rees DA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1966-72. PubMed ID: 19318448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3773-9. PubMed ID: 16849414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.
    Callies F; Fassnacht M; van Vlijmen JC; Koehler I; Huebler D; Seibel MJ; Arlt W; Allolio B
    J Clin Endocrinol Metab; 2001 May; 86(5):1968-72. PubMed ID: 11344193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.
    Christiansen JJ; Andersen NH; Sørensen KE; Pedersen EM; Bennett P; Andersen M; Christiansen JS; Jørgensen JO; Gravholt CH
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):426-33. PubMed ID: 17302879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    Arlt W; Callies F; van Vlijmen JC; Koehler I; Reincke M; Bidlingmaier M; Huebler D; Oettel M; Ernst M; Schulte HM; Allolio B
    N Engl J Med; 1999 Sep; 341(14):1013-20. PubMed ID: 10502590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ; Gravholt CH; Fisker S; Svenstrup B; Bennett P; Veldhuis J; Andersen M; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen replacement in adolescents and young women with hypopituitarism.
    Bilger M; Speraw S; LaFranchi SH; Hanna CE
    J Pediatr Endocrinol Metab; 2005 Apr; 18(4):355-62. PubMed ID: 15844469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial.
    van Thiel SW; Romijn JA; Pereira AM; Biermasz NR; Roelfsema F; van Hemert A; Ballieux B; Smit JW
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3295-303. PubMed ID: 15797966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHEA replacement in women with adrenal insufficiency--pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition.
    Arlt W; Callies F; Allolio B
    Endocr Res; 2000 Nov; 26(4):505-11. PubMed ID: 11196420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
    Yeung TW; Li RH; Lee VC; Ho PC; Ng EH
    J Clin Endocrinol Metab; 2013 Jan; 98(1):380-8. PubMed ID: 23144466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R; Barbetta L; Dall'Asta C; Salvaggio F; Gala C; Beck-Peccoz P; Ambrosi B
    J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ; O'Keane V; Miell JP
    Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison MC; Haller I; Rabkin J
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ; Nolan JJ; Nelson JC; Yen SS
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.